Ironwood Pharmaceuticals (IRWD) Cash from Operations (2016 - 2026)
Ironwood Pharmaceuticals' Cash from Operations history spans 16 years, with the latest figure at 74575000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 390.17% to 74575000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 127044000.0, a 22.69% increase, with the full-year FY2025 number at 127044000.0, up 22.69% from a year prior.
- Cash from Operations hit 74575000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from 47583000.0 in the prior quarter.
- Over the last five years, Cash from Operations for IRWD hit a ceiling of 80171000.0 in Q1 2023 and a floor of 15068000.0 in Q2 2025.
- Historically, Cash from Operations has averaged 47483900.0 across 5 years, with a median of 48075500.0 in 2021.
- The widest YoY moves for Cash from Operations: up 390.17% in 2025, down 145.03% in 2025.
- Tracing IRWD's Cash from Operations over 5 years: stood at 64568000.0 in 2021, then increased by 22.63% to 79182000.0 in 2022, then crashed by 54.74% to 35834000.0 in 2023, then plummeted by 57.54% to 15214000.0 in 2024, then skyrocketed by 390.17% to 74575000.0 in 2025.
- Business Quant data shows Cash from Operations for IRWD at 74575000.0 in Q4 2025, 47583000.0 in Q3 2025, and 15068000.0 in Q2 2025.